Dr Lee reports on risk of melanoma and NMSC risk in RA in cohort study using propensity score matching. No difference in risk between MTX and HCQ overall. Increase BCC in MTX (HR 1.32) but less SCC (HR 0.77) @rheumnow #ACR20 Abstr#1001 https://t.co/LDWgfGK9LS

5yr DESIR cohort data estimated incidence rate of uveitis at 1.3/100p-y; over five years, uveitis was associated w/ dactylitis, biologic and sacroiliac MRI inflammation. #ABS1304 #ACR20 @RheumNow https://t.co/qmXlY7PmBB

• Uveitis Occurrence in Early Inflammatory Back Pain: Five Years Data from a Pros…

Important thoughts- how do we actually use the biologics in practice for the rare diseases that do not have many FDA approved options? @RheumNow #ACR20 abstract 1429 https://t.co/SsYC1kF5uv

Shifting Treatment Paradigms in Psoriatic Arthritis: Dr. Eric Ruderman (@JointMD) Chicago-based Dr. Eric Ruderman discussed the shifting treatment paradigms in psoriatic arthritis by reviewing abstracts #0504 and #2026 at #ACR20. https://t.co/jsLkgWG63v https://t.co/h3r2oapOij

• https://bit.ly/3eEfXIj

Nintedanib in rheum ILD (RA/SSc/CTD) I appreciate the volumes might not seem like much, but: - in first 1y Rx 20% more are spared a FVC decline>10% - biggest diff in UIP-like pattern With the right patient selection, nintedanib does have its place! #ACR20 ABST1048/1049 @RheumNow https://t.co/jGZdR84bBU

Time-trends analysis of in-hospital mortality in #vasculitis in the US shows it to have significantly declined in this population from 1998 to 2014. Abs#1423 #ACR20 @RheumNow https://t.co/TTI4DJiCRk

• Declining In-Hospital Mortality in Vasculitis: A 17-year U.S. National Study - …

Corkscrew hairs and swollen knee - what's your diagnosis? TM01 #ACR20 @RheumNow https://t.co/jOkI94AKr6

Please take the new telemedicine survey- how can we help our patients during these unique times! @RheumNow #ACR20 https://t.co/n2jFfh1N9N

• https://twitter.com/psufka/status/1325445685630660611

So much more work to be done- the traditional tools for estimating CVD in rheumatic patients are likely not accurate especially patients with SLE- abstract 1286 @RheumNow #acr20 https://t.co/L6Z1fsO2he

#ABS1303 shows ASAS modification of Berlin algorithm showed optimal balance between sensitivity and specificity and represented the preferred referral strategy for patients presenting w/ undiagnosed back pain & extra-articular features. #ACR20 @RheumNow https://t.co/10VdKC3E75 https://t.co/RgC7K3V8TB

• Performance of Three Referral Algorithms for Diagnosing Axial Spondyloarthritis…

Patients diagnosed w/ #ANCA #vasculitis aged >75yrs have lower risk of relapse than pts 65-75yrs. Pts >75yrs less likely to be treated w/ immunosuppression & steroids but do benefit from this treatment when it is required. Abs#1417 #ACR20 @RheumNow https://t.co/stTAcioiQG

• Risk of Relapse of ANCA-associated Vasculitis in Patients of 75 Years and Older…

Excellent case - great job! @RheumNow #ACR20 #TM05 https://t.co/obE7KLD68m

• https://twitter.com/MeralElRamahiMD/status/1325443416575111169

Dr @AliDuarteMD presents on incidence of SLE over last 40 years, 29% increase overall, and doubled in males. Overall cyclical pattern. Abstr#1024 #ACR20 @rheumnow https://t.co/SSVY0U0SIg

#sjogren #syndrome poster session #ACR20 @RheumNow Clinical characteristics: lung, pregnancy,smoking, cervical lesions, anti La, childhood. https://t.co/QN4FVvQrYN